glp-1 ra vs glp-1 gip/glp-1 Comparison between and the GLP-1/GIP dual agonist GIP and GLP‐1, the two – Cardiovascular and mortality outcomes with

As AFib continues to affect more patients worldwide, clinicians need new strategies to reduce risk and improve long-term outcomes, presenting author Kenneth Bilchick, MD, professor of cardiovascular medicine at the University of Virginia, explained in a statement These findings suggest GLP-1-RAs may influence heart rhythm through mechanisms beyond weight loss

Switching too early can create repeated learning curves without giving your body sufficient time to respond

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

Warning: If you are pregnant, nursing, taking any medication, or have any medical condition, consult a health care professional before use

GLP-1 Agonists: A Clinical Comparison Framework Choosing between phentermine and GLP-1 agonists requires understanding how each addresses weight loss at a physiological level

Most reproductive endocrinologists recommend discontinuing GLP-1 therapy before attempting conception or immediately upon learning of pregnancy